392 related articles for article (PubMed ID: 34069523)
1. Not Just a Bystander: The Emerging Role of Astrocytes and Research Tools in Studying Cognitive Dysfunctions in Schizophrenia.
Chang CY; Luo DZ; Pei JC; Kuo MC; Hsieh YC; Lai WS
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069523
[TBL] [Abstract][Full Text] [Related]
2. [Role of astrocytes in alterations of glutamatergic neurotransmission in schizophrenia].
Kolomeets NS
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):110-117. PubMed ID: 25945378
[TBL] [Abstract][Full Text] [Related]
3. Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia.
Matos M; Shen HY; Augusto E; Wang Y; Wei CJ; Wang YT; Agostinho P; Boison D; Cunha RA; Chen JF
Biol Psychiatry; 2015 Dec; 78(11):763-74. PubMed ID: 25869810
[TBL] [Abstract][Full Text] [Related]
4. Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia.
Xia M; Abazyan S; Jouroukhin Y; Pletnikov M
Schizophr Res; 2016 Sep; 176(1):72-82. PubMed ID: 25468180
[TBL] [Abstract][Full Text] [Related]
5. Intracellular signaling and approaches to the treatment of schizophrenia and associated cognitive impairment.
Snyder GL; Vanover KE
Curr Pharm Des; 2014; 20(31):5093-103. PubMed ID: 24345266
[TBL] [Abstract][Full Text] [Related]
6. Dopamine dysregulation in the prefrontal cortex relates to cognitive deficits in the sub-chronic PCP-model for schizophrenia: A preliminary investigation.
McLean SL; Harte MK; Neill JC; Young AM
J Psychopharmacol; 2017 Jun; 31(6):660-666. PubMed ID: 28441905
[TBL] [Abstract][Full Text] [Related]
7. Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments.
Petrelli F; Dallérac G; Pucci L; Calì C; Zehnder T; Sultan S; Lecca S; Chicca A; Ivanov A; Asensio CS; Gundersen V; Toni N; Knott GW; Magara F; Gertsch J; Kirchhoff F; Déglon N; Giros B; Edwards RH; Mothet JP; Bezzi P
Mol Psychiatry; 2020 Apr; 25(4):732-749. PubMed ID: 30127471
[TBL] [Abstract][Full Text] [Related]
8. Glia-related genes and their contribution to schizophrenia.
Wang C; Aleksic B; Ozaki N
Psychiatry Clin Neurosci; 2015 Aug; 69(8):448-61. PubMed ID: 25759284
[TBL] [Abstract][Full Text] [Related]
9. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
10. How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?
Kondziella D; Brenner E; Eyjolfsson EM; Sonnewald U
Neurochem Int; 2007 Jan; 50(2):291-301. PubMed ID: 17084946
[TBL] [Abstract][Full Text] [Related]
11. Genetic Disruption of System xc-Mediated Glutamate Release from Astrocytes Increases Negative-Outcome Behaviors While Preserving Basic Brain Function in Rat.
Hess EM; Kassel SN; Simandl G; Raddatz N; Maunze B; Hurley MM; Grzybowski M; Klotz J; Geurts A; Liu QS; Choi S; Twining RC; Baker DA
J Neurosci; 2023 Mar; 43(13):2349-2361. PubMed ID: 36788029
[TBL] [Abstract][Full Text] [Related]
12. PDE Inhibitors for the Treatment of Schizophrenia.
Snyder GL; Vanover KE
Adv Neurobiol; 2017; 17():385-409. PubMed ID: 28956340
[TBL] [Abstract][Full Text] [Related]
13. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Nabeshima T; Mouri A; Murai R; Noda Y
Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
[TBL] [Abstract][Full Text] [Related]
14. Basic Neuroscience Illuminates Causal Relationship Between Sleep and Memory: Translating to Schizophrenia.
Pocivavsek A; Rowland LM
Schizophr Bull; 2018 Jan; 44(1):7-14. PubMed ID: 29136236
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte function from information processing to cognition and cognitive impairment.
Santello M; Toni N; Volterra A
Nat Neurosci; 2019 Feb; 22(2):154-166. PubMed ID: 30664773
[TBL] [Abstract][Full Text] [Related]
16. [Cognition, schizophrenia and the effect of antipsychotics].
Stip E
Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
[TBL] [Abstract][Full Text] [Related]
17. Glutamate and modeling of schizophrenia symptoms: review of our findings: 1990-2014.
Gargiulo PÁ; Landa De Gargiulo AI
Pharmacol Rep; 2014 Jun; 66(3):343-52. PubMed ID: 24905508
[TBL] [Abstract][Full Text] [Related]
18. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
Goto Y; Grace AA
Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
[TBL] [Abstract][Full Text] [Related]
19. An emerging role of astrocytes in vascular contributions to cognitive impairment and dementia.
Price BR; Norris CM; Sompol P; Wilcock DM
J Neurochem; 2018 Mar; 144(5):644-650. PubMed ID: 29222909
[TBL] [Abstract][Full Text] [Related]
20. Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.
Managò F; Mereu M; Mastwal S; Mastrogiacomo R; Scheggia D; Emanuele M; De Luca MA; Weinberger DR; Wang KH; Papaleo F
Cell Rep; 2016 Aug; 16(8):2116-2128. PubMed ID: 27524619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
